Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine : a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

COL MIG-202 study group

doi:10.1016/S1474-4422(12)70047-9

Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine : a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

COL MIG-202 study group

Research output: Contribution to journal › Article › Scientific › peer-review

173 Citations (Scopus)

Original language	English
Pages (from-to)	405-413
Journal	LANCET NEUROLOGY
Volume	11
Issue number	5
DOIs	https://doi.org/10.1016/S1474-4422(12)70047-9
Publication status	Published - 2012
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 3

Access to Document

10.1016/S1474-4422(12)70047-9

Cite this

@article{cda9c6fa86234712a2673ab0d24317eb,

title = "Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine : a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study",

author = "\{COL MIG-202 study group\} and Markus F{\"a}rkkil{\"a} and Hans-Christoph Diener and Gilles G{\'e}raud and Miguel L{\'a}inez and Jean Schoenen and Nadja Harner and Alison Pilgrim and Uwe Reuter and Marja-Liisa Sumelahti",

year = "2012",

doi = "10.1016/S1474-4422(12)70047-9",

language = "English",

volume = "11",

pages = "405--413",

journal = "LANCET NEUROLOGY",

issn = "1474-4422",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine : a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

AU - COL MIG-202 study group

AU - Färkkilä, Markus

AU - Diener, Hans-Christoph

AU - Géraud, Gilles

AU - Láinez, Miguel

AU - Schoenen, Jean

AU - Harner, Nadja

AU - Pilgrim, Alison

AU - Reuter, Uwe

AU - Sumelahti, Marja-Liisa

PY - 2012

Y1 - 2012

U2 - 10.1016/S1474-4422(12)70047-9

DO - 10.1016/S1474-4422(12)70047-9

M3 - Article

SN - 1474-4422

VL - 11

SP - 405

EP - 413

JO - LANCET NEUROLOGY

JF - LANCET NEUROLOGY

IS - 5

ER -